MEMBER LOG-IN

LOGIN HELP

LogIn Help

SIGN UP

CLICK TO CREATE AN ACCOUNT
JOIN US or FOLLOW US HERE go to linkedIn go to twitter

New Account Registration

Yes No

Please sign me up for these other regions too:

Boston BioBreak
Philly BioBreak
New Jersey BioBreak
JPMorgan BioBreak
Europe BioBreak
All Regions
Yes No

Refer a Friend

Reset Password

Philly BioBreak – Events Archive

Please see below for attendees and images from this event.

Philly Philly BioBreak Summer Social July 12, 2017 5:30-8:00 pm

Co-Hosts for this event

Name Company
(No co-hosts found)

Attendees at this event

Mahmoud Mahmoudian Purdue Pharma
Jamil Beg 5AM Ventures
Scott Shandler Longevity Biotech
Shawn Bridy Bridy Advisors
Benjamin Doranz Integral Molecular
Phil Heifetz Saturn Care
Russel Kaufman Pappas-Capital
Brian MacDonald self
Sandy Matalonis Iroko Pharmaceuticals
Rifat Pamukcu Midway Pharmaceuticals
H Joseph Reiser Mito Biopharm
Michael Saporito Marinus Pharmaceuticals
Barbara Schilberg BioAdvance
Kevin Taylor Kerberos BioPharma
Thomas Tillett MBF Therapeutics
Geeta Vemuri Agent Capital
Clarence Young Velicept Therapeutics
Rhonda Gilbert R Y Gilbert Associates
Chris Miller Pepper Hamilton
Kate Shay Duane Morris
Barb Carlin Egalet
Sandra Stoneman Duane Morris
Tom Logan BTG
David Arvan AstraZeneca
Shawn O'Brien Melanovus Therapeutics
Marie Lindner Novartis
Harry Atkins Aralez Pharmaceuticals US Inc.
Kathleen McGowan VaxInnate Corporation
James Altland Keystone Nano
Matt Handel Recensa Therapeutics
Sarabjit Ashta Prev: Dr. Reddy's Labs
Joan Lau Militia Hill Ventures
Michael Richardson Princeton BioPharma, LLC
Rachel Cervantes University City Science Center
Michael Lark Trevena
Roberto Cuca Trevena
Rick Winneker
Lawrence Brown Galactica Pharmaceuticals
Ben Goldberg BSG Advisors
Martin Lehr Context Therapeutics
Scott Megaffin Churchill Pharmaceuticals
Alexey Melishchuk Drexel Tech Transfer
Aaron Rabinowitz BakerHostetler
Patrick Dougherty GlaxoSmithKline
Michael Nagy Rutgers University
Jeremy Goldberg Torreya Advisors
Nikolaos Tezapsidis Neurotez
Morgan Conn CallisBio
Josh Albert KleinHersh
Chris Slavinsky Pfizer
Lorraine Marchand Cognizant
Alex Levit OptiNose
Daniel Kennedy GlaxoSmithKline
Doug Hicks iBio, Inc.
Pascale Marty-Ethgen Janssen Pharmaceuticals
Andrew Reaume Melior Discovery
Michael Shine NovaPharm Therapeutics
Ira Wallace Keiretsu Forum
Tauseef Butt Progenra
Matthew Hollenbeck Stryker
John Berman Chondrial Therapeutics
Richard Mangano Drexel University College of Medicine
Steven Pessagno GlaxoSmithKline
Christopher Schaber Soligenix
Jeff Baxter VBI Vaccines
John Gledhill Evogen, Inc.
Scott Dax Cersci Therapeutics
Dora Mitchell Penn Center for Innovation
Vinod Ramachandran Dr. Reddy's Canada
Christopher Burns VenatoRx Pharmaceuticals
Sharon Willis Integral Molecular
Anjan Aralihalli Glypharma
Harish Krishnaswamy Domain Associates
Lauren Kaskiel Spark Therapeutics
Rob Sterling Ichor Therapeutics
Marc Hixson Coeus Group
Corey Jacklin AvantFluor
Martin Phillips Tarnhelm Therapeutics
Joseph Salvino Wistar Institute
Dawn Eringis Integral Molecular
Nick DAleandro Janssen
Scott Kain Impax Laboratories, Inc.
Chris Cramer CytoSorbents Corporation
Cheryl Paes Integral Molecular
John Farah OncoScire Therapeutics
Chris Flores Janssen
Stephanie Stehman Osage University Partners
Timothy Atkins Pepper Hamilton
Matthew Cohen Osage University Partners
Joseph Rucker Integral Molecular
Scott Jones Pepper Hamilton
Felix Kim Context Therapeutics
Todd Johnson Optum
Jane Hollingsworth Militia Hill Ventures
Joseph Zack Excalivir Diagnostics
Gwen Melincoff Gemini Advisors LLC
Jonathan Rubin Alcobra Ltd
Maurice T. Hampton Telesis Therapeutics, LLC
Cathy Sohn Jazz Pharmaceuticals
Mark Strobeck Egalet Corporation
Eric Mortensen CytoSorbents Inc.
Hans Huber BioTD Strategies
Michael Dishowitz Penn Center for Innovation
Heather Steinman Wistar Institute
Matt Rieke Johnson & Johnson
Michael Seggev Teva
Mike Diem Aevi Genomic Medicines
Andrew meadow Conceivex, Inc.
Kathie Jordan Drexel University
Ken Kovan Phelix Therapeutics LLC
Robert Biggs Morgan Stanley
Todd Abrams Temple University
David Baker Alcobra Pharma
Frank Walsh Ossianix
Viviane Martin University of Pennsylvania
Jared Kaleck Klein Hersh International
Stephen Popielarski Enzium, Inc.
Jie Liu Torreya Partners
Laurie Actman PCI
Steve Farina ProZyme Inc.
Frank Leu Novapeutics LLC
David Soergel Trevena
Ivan Joseph Hsiri Therapeutics
James Murphy VenatoRx Pharmaceuticals
Dennis Gross Pennsylvania Drug Discovery Institute
Edwin Holland Cenoxsys, LLC
Lawson Macartney Viking Therapeutics
Gary Fletcher SphereVis
erika geimonen Amring Pharmaceuticals
Matthew Lorenzi Janssen Oncology
Armin Rump Otsuka Pharmaceutical
Susan Dillon Janssen R&D
Kirsten Leute Osage University Partners
Craig Matturro 1315 Capital
Lisa DeMarco GlaxoSmithKline
Eric Fink Jazz Pharmaceuticals
Ben Cowen ImmunoMet Therapeutics
Peter Harwin Fairmount Funds
Allison Greenfield Klein Hersh
Moji James Iroko Pharmaceuticals
Sara Merriman Brandywine Realty Trust
Paul Stead Inovio Pharmaceuticals
Karen Krumeich Soligenix, Inc
Fredric Cohen Strongbridge Biopharma
Arun Swaminathan Lynkogen Inc.
Clare Kahn
William Williams BriaCell Therapeutics Corp.
rivka Kreitman Teva
Ben Dibling University of Pennsylvania
Felix Chapovsky MD TarMeta Biosciences, Inc.
Andrew Taylor Angel Medical
Terry Pompey Medallion Healthcare
Debbie Buchwald Drexel University, Office of Corporate Relations and Economic Development
George Dytko GDLin Consultants
Kalyan Anumula Not yet
Jon Congleton Nivalis Therapeutics
Melissa Sherman MOBILion Systems Inc.
Dennis Jackman CSL Behring
Mark Turco University of Pennsylvania
Rohit Mehta Iroko Pharma
Patrick Hayakawa Life Sciences PA
Jennifer Levy Coalition to Cure Calpain 3
Ira Spector SFA Therapeutics
Althea Stillman IP Group Inc
Conrad Wang HealthCare Royalty Partners
Sarah Spencer GlaxoSmithKline
Stewart McCallum Recro Pharma Inc.
John Osborn
Deepak Lala Vitae (Allergan affiliate)
Charles Morris PsiOxus
Chris Dougherty Jazz Pharmaceuticals
Tyler Chavez Spark Therapeutics
Rose Ritts Jefferson Health
Tom Wilton UPenn Gene Therapy Program
Stephen Condon VenatoRx
Richard Fitzgerald QR Pharma, Inc.
Lynn Marks GSK
Tom Penn MVP Capital Partners
Bruce Willner Graphene Frontiers
Brian Jones PIPV Capital
Prabhpreet Gill University of Delaware
Suresh Singh HotSpot Therapeutics
Paul Gillespie Roche
Jerri Ann Thatcher Independent Consultant
Scott Wolkenberg Merck and Co.
Amanda Fleming 1315 Capital
J. Christopher LiPuma Kastle Therapeutics
haruhiko sugino Otsuka pharmaceutical
Sanjay Kumar GlaXoSmithKline
Kamil Ali-Jackson Aclaris Therapeutics, Inc.
Karyn O'Neil Janssen R&D
Jun Huangpu NeoVitaBiopharm
Rachael Hagan NDI Therapeutics
Neal Lemon Uniiversity of Pennsylvania - PCI
Amy Williams FemmePharma

Become a Supporter

For more information about sponsorship, please email us at sponsorship@biobreak.org.

Web design: GillFishmanDesign.com